NEW YORK (GenomeWeb News) – Gentronix today said that it has received a French research tax credit approval for the years 2012-2014.

The credit allows eligible research-intensive French companies who are subject to corporate tax in France the ability to claim tax relief on costs generated in R&D requirements that are outsourced to Gentronix. The firm is based in Manchester, UK, and provides genotoxicity screening products and services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.